Antimalarial activity and toxicity of Garcinia mangostana L. pericarp extracts and major xanthones: A systematic review of in vitro and in vivo studies
Journal of Pharmacy & Pharmacognosy Research · 01.03.2026 · 14 (2) · 2495
DOI: 10.56499/jppres_14.2.2495 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Pharmacy & Pharmacognosy Research, online erschienen am 01.03.2026. Verfasst von Joanne T. Winata und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Context
Malaria morbidity remains high, and resistance to antimalarial drugs and diagnostics continues to expand.
Aims
To systematically evaluate the in vitro/in vivo antimalarial efficacy and toxicity of Garcinia mangostana L. pericarp extracts (MP)/fractions and major xanthones.
Methods
A PRISMA 2020 systematic review was performed and registered in PROSPERO. Searches were conducted in six databases up to March 30, 2025, using predefined keywords. Original English-language studies reporting the antimalarial activity and/or toxicity of MP extracts, fractions, or major xanthones in vitro/in vivo were included. Risk of bias was assessed using SciRAP (in vitro) and ToxRTool (in vivo). Due to methodological heterogeneity, findings were synthesized descriptively.
Results
From 3,785 records, 20 studies (16 in vitro; 4 in vivo) were included. EEs and non-polar fractions (e.g., dichloromethane, hexane) were frequently reported as active to very active in vitro. α-Mangostin (α-MG) exhibited activity against Plasmodium falciparum strains across assays (IC50 range: 2.2–36.1 μM), and intraperitoneal administration in rodent malaria models was associated with high chemosuppression (>80%) in a single study; oral activity was lower. Low acute toxicity was observed at high doses; however, chronic exposure was associated with hepatic and renal alterations in some studies. Limitations of the evidence: Reporting quality was variable. Although all in vivo studies were classified as reliable without restrictions, the risk of bias was frequently high in vitro, and reporting on cytotoxicity and selectivity was inconsistent across studies, limiting the ability to draw conclusions for clinical application.
Conclusions
MP-derived materials, particularly α-MG, exhibit experimental antimalarial activity. However, heterogeneity, incomplete reporting, and limitations regarding oral exposure warrant standardized studies on efficacy, selectivity, and pharmacokinetics.
Zitieren
APA
Winata, J. T., Nugroho, A. K., Murti, Y. B., & Nurrochmad, A. (2026). Antimalarial activity and toxicity of Garcinia mangostana L. pericarp extracts and major xanthones: A systematic review of in vitro and in vivo studies. Journal of Pharmacy & Pharmacognosy Research, 14(2), 2495. https://doi.org/10.56499/jppres_14.2.2495
Vancouver
Winata JT, Nugroho AK, Murti YB, Nurrochmad A. Antimalarial activity and toxicity of Garcinia mangostana L. pericarp extracts and major xanthones: A systematic review of in vitro and in vivo studies. Journal of Pharmacy & Pharmacognosy Research. 2026;14(2):2495. doi:10.56499/jppres_14.2.2495
BibTeX
@article{Winata2026,
author = {Winata, Joanne T. and Nugroho, Ahmad K. and Murti, Yosi B. and Nurrochmad, Arief},
title = {Antimalarial activity and toxicity of Garcinia mangostana L. pericarp extracts and major xanthones: A systematic review of in vitro and in vivo studies},
journal = {Journal of Pharmacy & Pharmacognosy Research},
year = {2026},
volume = {14},
number = {2},
pages = {2495},
doi = {10.56499/jppres_14.2.2495}
}
EUVIMED